Canadian Press NewsAlert: Well being Canada approves Pfizer antiviral

OTTAWA – Well being Canada has accepted Pfizer’s antiviral therapy for COVID-19.

The authorization posted to the Well being Canada web site this morning says the therapy is greenlighted for grownup sufferers with delicate or average COVID-19 who’re additionally at excessive danger of turning into extra significantly sick.

Well being Canada didn’t authorize it to be used on youngsters.

It’s also not licensed to be used on sufferers who’re already hospitalized due to COVID-19.

Paxlovid is a therapy that makes use of a mix of medication to stop the virus that causes COVID-19 from replicating as soon as it has contaminated a affected person.

Scientific trials present it was virtually 90 per cent efficient at stopping severe sickness in higher-risk sufferers who acquired it inside the first 5 days of being contaminated.

Extra Coming.

This report by The Canadian Press was first printed Jan. 17, 2021.


Conversations are opinions of our readers and are topic to the Code of Conduct. The Star doesn’t endorse these opinions.


Leave a Reply

Your email address will not be published.